What payers may overlook when weighing the cost of proton treatment
Allegedly enriched insurance providers while underpaying on out-of-network claims
Has reportedly been looking for a buyer since November
Q&A with Vivek Sachdev, director of engineering for Invasive Cardiology at GE HealthCare